The Foundation confirmed its partnership with Links Group at a healthcare conference in Beijing earlier this week.
Links Group will provide PR and media communications support to the Foundation on its upcoming healthcare PR education and commucations push on cervical cancer targeting Chinese women.
Global pharmaceutical company MSD will launch a new cervical cancer vaccine into the China market at the end of this year or early 2012, pending approval by China's SFDA.